Role of miR-6814-5p for the formation of T5, a heparanase variant, in renal cell carcinoma
Abstract
Purpose: The aim of this study is to investigate whether the overexpression of human heparanase protein (HPSE) alternative variant protein called T5 is caused by increased expression of miR-6814-5p in human renal cell carcinoma (RCC) cases. In addition, the possible correlation between the clinical parameters of RCC cases and the expression levels of T5 and miR-6814-5p was evaluated.
Materials and Methods: T5 and miR-6814-5p expression analysis was performed on ready-to-use RCC cDNA panel by qPCR method. This panel included 48 cDNA samples obtained from tumor tissues of 10 stage-1, 5 stage-2, 13 stage-3 and 11 stage-4 RCC patients and normal kidney tissues from 9 healthy individuals.
Results: There was no significant correlation between TNM stages, Fuhrman nuclear grade and histological type and miR-6814-5p and T5 expressions. The expression level of miR-6814-5p in RCC tumor tissues was about 8-fold higher and the T5 expression level about 5-fold higher than healthy controls. MiR-6814-5p and T5 expression changes were statistically significantly correlated with neutrophil/lymphocyte ratio of RCC cases.
Conclusion: MiR-6814-5p may play a role in the formation mechanism of T5 in RCC.
Keywords
Renal cell carcinoma , heparanase , gene expression regulation , miR-6814-5p
References
- 1) Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell. 2009; 136: 777–793.
- 2) Barash U, Cohen V, Arvatz G, Gingis S, Levy F. A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics. FASEB J. 2010; 24: 1239–1248.
- 3) Von M, Bernhart SH, Pansky A, Richter C, Kohl T, Deckert M, Fries JW. Beyond the 3′ UTR binding–microRNA-induced protein truncation via DNA binding. Oncotarget. 2018; 9(67): 32855.
- 4) Saydam F, Değirmenci İ, Güneş HV. MicroRNAs and cancer. Dicle Med J. 2011; 38 (1): 113-120.
- 5) Ergün, S. In silico analysis of biomarker potentials of miRNA-mediated ceRNAs in prostate cancer. Dicle Med J. 2018; 45(4): 415-429.
- 6) Wong N, Wang X. miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 2014; 43: D146-D152.
- 7) Rennie W, Liu C, Carmack, CS, Wolenc A, Kanoria S, Lu J, Ding Y. STarMir: a web server for prediction of microRNA binding sites. Nucleic Acids Res. 2014; 42: W114-W118.
- 8) Yang SF, Hsu HL, Chao TK, Hsiao CJ, Lin YF, Cheng CW. Annexin A2 in renal cell carcinoma: expression, function, and prognostic significance. Urol Oncol Semin Ori. 2015; 33(1), 22-e11.
- 9) Ergün S, Altay DU, Güneş S, Büyükalpelli R, Karahan SC, Tomak L, Abur Ü. Tr-KIT/c-KIT ratio in renal cell carcinoma. Mol Biol Rep. 2019; 46(5): 5287-94.
- 10) Akgun S, Kucuksayan H, Tokgun O, Karagur ER, Can O, Akca H. miR-548a-3p, miR-548as-3p and miR-8078 are responsible for NSCLC. 2016 Wiley-Blackwell.
